Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Pulford, K; Morris, SW; Mason, DY
   Anaplastic lymphoma kinase proteins and malignancy
   CURRENT OPINION IN HEMATOLOGY
   
   K. Pulford et al., "Anaplastic lymphoma kinase proteins and malignancy", CURR OPIN H, 8(4), 2001, pp. 231-236
2. Turturro, F; Frist, AY; Arnold, MD; Seth, P; Pulford, K
   Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the anti proliferative effect of p27(Kip1)
   ONCOGENE
   
   F. Turturro et al., "Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the anti proliferative effect of p27(Kip1)", ONCOGENE, 20(33), 2001, pp. 4466-4475
3. Tort, F; Pinyol, M; Pulford, K; Roncador, G; Hernandez, L; Nayach, I; Kluin-Nelemans, HC; Kluin, P; Touriol, C; Delsol, G; Mason, D; Campo, E
   Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma
   LABORATORY INVESTIGATION
   
   F. Tort et al., "Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma", LAB INV, 81(3), 2001, pp. 419-426
4. Camilleri-Broet, S; Audouin, J; Ferme, C; Briere, J; Pulford, K; Gaulard, P; Divine, M; Macintyre, E; Delsol, G; Berger, F
   ALK is not expressed in Hodgkin disease
   BLOOD
   
   S. Camilleri-Broet et al., "ALK is not expressed in Hodgkin disease", BLOOD, 97(6), 2001, pp. 1901-1902
5. Boulland, ML; Wechsler, J; Bagot, M; Pulford, K; Kanavaros, P; Gaulard, P
   Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins
   HISTOPATHOLOGY
   
   M.L. Boulland et al., "Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins", HISTOPATHOL, 36(2), 2000, pp. 136-144
6. ten Berge, RL; Oudejans, JJ; Ossenkoppele, GJ; Pulford, K; Willemze, R; Falini, B; Chott, A; Meijer, CJLM
   ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination
   JOURNAL OF CLINICAL PATHOLOGY
   
   R.L. ten Berge et al., "ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination", J CLIN PATH, 53(6), 2000, pp. 445-450
7. Trinei, M; Lanfrancone, L; Campo, E; Pulford, K; Mason, DY; Pelicci, PG; Falini, B
   A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
   CANCER RESEARCH
   
   M. Trinei et al., "A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma", CANCER RES, 60(4), 2000, pp. 793-798
8. Pulford, K; Falini, B; Banham, AH; Codrington, D; Roberton, H; Hatton, C; Mason, DY
   Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
   BLOOD
   
   K. Pulford et al., "Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma", BLOOD, 96(4), 2000, pp. 1605-1607
9. Stein, H; Foss, HD; Durkop, H; Marafioti, T; Delsol, G; Pulford, K; Pileri, S; Falini, B
   CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
   BLOOD
   
   H. Stein et al., "CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features", BLOOD, 96(12), 2000, pp. 3681-3695
10. Touriol, C; Greenland, C; Lamant, L; Pulford, K; Bernard, F; Rousset, T; Mason, DY; Delsol, G
    Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
    BLOOD
    
    C. Touriol et al., "Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)", BLOOD, 95(10), 2000, pp. 3204-3207
11. Lamant, L; Pulford, K; Bischof, D; Morris, SW; Mason, DY; Delsol, G; Mariame, B
    Expression of the ALK tyrosine kinase gene in neuroblastoma
    AMERICAN JOURNAL OF PATHOLOGY
    
    L. Lamant et al., "Expression of the ALK tyrosine kinase gene in neuroblastoma", AM J PATH, 156(5), 2000, pp. 1711-1721
12. Banham, AH; Colonna, M; Cella, M; Micklem, KJ; Pulford, K; Willis, AC; Mason, DY
    Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
    JOURNAL OF LEUKOCYTE BIOLOGY
    
    A.H. Banham et al., "Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily", J LEUK BIOL, 65(6), 1999, pp. 841-845
13. Pulford, K; Delsol, G; Roncador, G; Biddolph, S; Jones, M; Mason, DY
    Immunohistochemical screening for oncogenic tyrosine kinase activation
    JOURNAL OF PATHOLOGY
    
    K. Pulford et al., "Immunohistochemical screening for oncogenic tyrosine kinase activation", J PATHOLOGY, 187(5), 1999, pp. 588-593
14. Dukers, DF; ten Berge, RL; Oudejans, JJ; Pulford, K; Hayes, D; Misere, JFMM; Ossenkoppele, GJ; Jaspars, LH; Willemze, R; Meijer, CJLM
    A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas
    JOURNAL OF CLINICAL PATHOLOGY
    
    D.F. Dukers et al., "A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas", J CLIN PATH, 52(2), 1999, pp. 129-136
15. Pulford, K; Jones, M; Banham, AH; Haralambieva, E; Mason, DY
    Lymphocyte-specific protein 1: A specific marker of human leucocytes
    IMMUNOLOGY
    
    K. Pulford et al., "Lymphocyte-specific protein 1: A specific marker of human leucocytes", IMMUNOLOGY, 96(2), 1999, pp. 262-271
16. Hernandez, L; Pinyol, M; Hernandez, S; Bea, S; Pulford, K; Rosenwald, A; Lamant, L; Falini, B; Ott, G; Mason, DY; Delsol, G; Campo, E
    TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations
    BLOOD
    
    L. Hernandez et al., "TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations", BLOOD, 94(9), 1999, pp. 3265-3268
17. Falini, B; Pulford, K; Pucciarini, A; Carbone, A; De Wolf-Peeters, C; Cordell, J; Fizzotti, M; Santucci, A; Pelicci, PG; Pileri, S; Campo, E; Ott, G; Delsol, G; Mason, DY
    Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
    BLOOD
    
    B. Falini et al., "Lymphomas expressing ALK fusion protein(s) other than NPM-ALK", BLOOD, 94(10), 1999, pp. 3509-3515
18. Rosenwald, A; Ott, G; Pulford, K; Katzenberger, T; Kuhl, J; Kalla, J; Ott, MM; Mason, DY; Muller-Hermelink, HK
    t(1;2)(q21;p23) and t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma
    BLOOD
    
    A. Rosenwald et al., "t(1;2)(q21;p23) and t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma", BLOOD, 94(1), 1999, pp. 362-364
19. Lamant, L; Dastugue, N; Pulford, K; Delsol, G; Mariame, B
    A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
    BLOOD
    
    L. Lamant et al., "A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation", BLOOD, 93(9), 1999, pp. 3088-3095
20. ten Berge, RL; Dukers, DF; Oudejans, JJ; Pulford, K; Ossenkoppele, GJ; de Jong, D; Misere, JFMM; Meijer, CJLM
    Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma
    BLOOD
    
    R.L. ten Berge et al., "Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma", BLOOD, 93(8), 1999, pp. 2688-2696
21. Jones, D; Fletcher, CDM; Pulford, K; Shahsafaei, A; Dorfman, DM
    The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma
    BLOOD
    
    D. Jones et al., "The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma", BLOOD, 93(10), 1999, pp. 3487-3493
22. Pulford, K; Falini, B; Cordell, J; Rosenwald, A; Ott, G; Muller-Hermelink, HK; MacLennan, KA; Lamant, L; Carbone, A; Campo, E; Mason, DY
    Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma
    AMERICAN JOURNAL OF PATHOLOGY
    
    K. Pulford et al., "Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma", AM J PATH, 154(6), 1999, pp. 1657-1663
23. GASCOYNE RD; WU CD; CHHANABHAI M; MORRIS SW; PULFORD K; MASON D; GREINER TC; CONNORS JM; VOSE JM; COLDMAN A; WEISENBURGER DD
    PROGNOSTIC-SIGNIFICANCE OF ALK ONCOGENE EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
    Modern pathology
    
    R.D. Gascoyne et al., "PROGNOSTIC-SIGNIFICANCE OF ALK ONCOGENE EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)", Modern pathology, 11(1), 1998, pp. 129-129
24. VERGIER B; BEYLOTBARRY M; PULFORD K; MICHEL P; BOSQ J; DEMURET A; BEYLOT C; DELAUNAY MM; AVRIL MF; DALAC S; BODEMER C; JOLY P; GROPPI A; DEMASCAREL A; BAGOT M; MASON DY; WECHSLER J; MERLIO JP
    STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS )
    The American journal of surgical pathology
    
    B. Vergier et al., "STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS )", The American journal of surgical pathology, 22(10), 1998, pp. 1192-1202
25. PILOZZI E; PULFORD K; JONES M; MULLERHERMELINK HK; FALINI B; RALFKIAER E; PILERI S; PEZZELLA F; DEWOLFPEETERS C; ARBER D; STEIN H; MASON D; GATTER K
    COEXPRESSION OF CD79A (JCB117) AND CD3 BY LYMPHOBLASTIC LYMPHOMA
    Journal of pathology
    
    E. Pilozzi et al., "COEXPRESSION OF CD79A (JCB117) AND CD3 BY LYMPHOBLASTIC LYMPHOMA", Journal of pathology, 186(2), 1998, pp. 140-143
26. TENBERGE RL; OUDEJANS JJ; PULFORD K; WILLEMZE R; MASON DY; MEIJER CJLM
    NPM-ALK EXPRESSION AS A DIAGNOSTIC MARKER IN CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS
    Journal of investigative dermatology
    
    R.L. Tenberge et al., "NPM-ALK EXPRESSION AS A DIAGNOSTIC MARKER IN CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS", Journal of investigative dermatology, 110(4), 1998, pp. 578-578
27. DELABESSE E; BERNARD M; MEYER V; SMIT L; PULFORD K; CAYUELA JM; RITZ J; BOURQUELOT P; STROMINGER JL; VALENSI F; MACINTYRE EA
    TAL1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS
    British Journal of Haematology
    
    E. Delabesse et al., "TAL1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS", British Journal of Haematology, 102(2), 1998, pp. 449-457
28. BENHARROCH D; MEGUERIANBEDOYAN Z; LAMANT L; AMIN C; BRUGIERES L; TERRIERLACOMBE MJ; HARALAMBIEVA E; PULFORD K; PILERI S; MORRIS SW; MASON DY; DELSOL G
    ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY
    Blood
    
    D. Benharroch et al., "ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY", Blood, 91(6), 1998, pp. 2076-2084
29. BEYLOTBARRY M; GROPPI A; VERGIER B; PULFORD K; MERLIO JP
    CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS
    Blood
    
    M. Beylotbarry et al., "CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS", Blood, 91(12), 1998, pp. 4668-4676
30. FALINI B; BIGERNA B; FIZZOTTI M; PULFORD K; PILERI SA; DELSOL G; CARBONE A; PAULLI M; MAGRINI U; MENESTRINA F; GIARDINI R; PILOTTI S; MEZZELANI A; UGOLINI B; BILLI M; PUCCIARINI A; PACINI R; PELICCI PG; FLENGHI L
    ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/
    The American journal of pathology
    
    B. Falini et al., "ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/", The American journal of pathology, 153(3), 1998, pp. 875-886
31. SU LD; SCHNITZER B; ROSS CW; VASEF M; MORI S; SHIOTA M; MASON DY; PULFORD K; HEADINGTON JT; SINGLETON TP
    THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/
    Journal of cutaneous pathology
    
    L.D. Su et al., "THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/", Journal of cutaneous pathology, 24(10), 1997, pp. 597-603
32. BISCHOF D; PULFORD K; MASON DY; MORRIS SW
    ROLE OF THE NUCLEOPHOSMIN (NPM) PORTION OF THE NON-HODGKINS LYMPHOMA-ASSOCIATED NPM-ANAPLASTIC LYMPHOMA KINASE FUSION PROTEIN IN ONCOGENESIS
    Molecular and cellular biology
    
    D. Bischof et al., "ROLE OF THE NUCLEOPHOSMIN (NPM) PORTION OF THE NON-HODGKINS LYMPHOMA-ASSOCIATED NPM-ANAPLASTIC LYMPHOMA KINASE FUSION PROTEIN IN ONCOGENESIS", Molecular and cellular biology, 17(4), 1997, pp. 2312-2325
33. MEGUERIANBEDOYAN Z; LAMANT L; HOPFNER C; PULFORD K; CHITTAL S; DELSOL G
    ANAPLASTIC LARGE-CELL LYMPHOMA OF MATERNAL ORIGIN INVOLVING THE PLACENTA - CASE-REPORT AND LITERATURE SURVEY
    The American journal of surgical pathology
    
    Z. Meguerianbedoyan et al., "ANAPLASTIC LARGE-CELL LYMPHOMA OF MATERNAL ORIGIN INVOLVING THE PLACENTA - CASE-REPORT AND LITERATURE SURVEY", The American journal of surgical pathology, 21(10), 1997, pp. 1236-1241
34. AUER I; PULFORD K; MASON DY; STROUD D; CONNORS JM; GASCOYNE RD
    PROGNOSTIC-SIGNIFICANCE OF P80 ALK1 EXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMAS(DLCL)/
    Laboratory investigation
    
    I. Auer et al., "PROGNOSTIC-SIGNIFICANCE OF P80 ALK1 EXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMAS(DLCL)/", Laboratory investigation, 76(1), 1997, pp. 695-695
35. PITTALUGA S; PULFORD K; WLODARSKA I; MASON DY; VANDENBERGHE H; DEWOLFPEETERS C; LEUVEN KU
    ALK-1 ANTIBODY STAINING PATTERN IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) AND ALCL-HODGKINS LIKE
    Laboratory investigation
    
    S. Pittaluga et al., "ALK-1 ANTIBODY STAINING PATTERN IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) AND ALCL-HODGKINS LIKE", Laboratory investigation, 76(1), 1997, pp. 768-768
36. WOOD KM; PARR A; JACK F; PULFORD K; LESSELLS AM; KRAJEWSKI AS; LEVISON DA; GOODLAD J; THOMPSON WD; LEE FD; HOME CHW; ANGUS B
    EXPRESSION OF THE P80 NPM ALK FUSION PROTEIN IN ANAPLASTIC LYMPHOMA/
    Journal of pathology
    
    K.M. Wood et al., "EXPRESSION OF THE P80 NPM ALK FUSION PROTEIN IN ANAPLASTIC LYMPHOMA/", Journal of pathology, 182, 1997, pp. 38-38
37. BEYLOTBARRY M; VERGIER B; PULFORD K; BOSQ MJ; DEMURET A; BEYLOT C; DELAUNAY MM; AVRIL MF; DALAC S; BODEMER C; JOLY P; BAGOT M; DEMASCAREL A; MANSON DY; WECHSLER J; MERLIO JP
    DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTEMIC CD30+ LYMPHOPROLIFERATIVE DISORDERS IS NOT SUPPORTED BY BIOLOGICAL DATA
    Journal of investigative dermatology
    
    M. Beylotbarry et al., "DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTEMIC CD30+ LYMPHOPROLIFERATIVE DISORDERS IS NOT SUPPORTED BY BIOLOGICAL DATA", Journal of investigative dermatology, 109(3), 1997, pp. 484-484
38. BANHAM AH; TURLEY H; PULFORD K; GATTER K; MASON DY
    THE PLASMA-CELL ASSOCIATED ANTIGEN DETECTABLE BY ANTIBODY VS38 IS THEP63 ROUGH ENDOPLASMIC-RETICULUM PROTEIN
    Journal of Clinical Pathology
    
    A.H. Banham et al., "THE PLASMA-CELL ASSOCIATED ANTIGEN DETECTABLE BY ANTIBODY VS38 IS THEP63 ROUGH ENDOPLASMIC-RETICULUM PROTEIN", Journal of Clinical Pathology, 50(6), 1997, pp. 485-489
39. KUEFER MU; LOOK AT; PULFORD K; BEHM FG; PATTENGALE PK; MASON DY; MORRIS SW
    RETROVIRUS-MEDIATED GENE-TRANSFER OF NPM-ALK CAUSES LYMPHOID MALIGNANCY IN MICE
    Blood
    
    M.U. Kuefer et al., "RETROVIRUS-MEDIATED GENE-TRANSFER OF NPM-ALK CAUSES LYMPHOID MALIGNANCY IN MICE", Blood, 90(8), 1997, pp. 2901-2910
40. DELSOL G; LAMANT L; MARIAME B; PULFORD K; DASTUGUE N; BROUSSET P; RIGALHUGUET F; ALSAATI T; CERRETTI DP; MORRIS SW; MASON DY
    A NEW SUBTYPE OF LARGE B-CELL LYMPHOMA EXPRESSING THE ALK KINASE AND LACKING THE 2-5-TRANSLOCATION
    Blood
    
    G. Delsol et al., "A NEW SUBTYPE OF LARGE B-CELL LYMPHOMA EXPRESSING THE ALK KINASE AND LACKING THE 2-5-TRANSLOCATION", Blood, 89(5), 1997, pp. 1483-1490
41. PULFORD K; LAMANT L; MORRIS SW; BUTLER LH; WOOD KM; STROUD D; DELSOL G; MASON DY
    DETECTION OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND NUCLEOLAR PROTEIN NUCLEOPHOSMIN (NPM)-ALK PROTEINS IN NORMAL AND NEOPLASTIC-CELLS WITH THE MONOCLONAL-ANTIBODY ALK1
    Blood
    
    K. Pulford et al., "DETECTION OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND NUCLEOLAR PROTEIN NUCLEOPHOSMIN (NPM)-ALK PROTEINS IN NORMAL AND NEOPLASTIC-CELLS WITH THE MONOCLONAL-ANTIBODY ALK1", Blood, 89(4), 1997, pp. 1394-1404
42. PITTALUGA S; WLODARSKA I; PULFORD K; CAMPO E; MORRIS SW; VANDENBERGHE H; DEWOLFPEETERS C
    THE MONOCLONAL-ANTIBODY ALK1 IDENTIFIES A DISTINCT MORPHOLOGICAL SUBTYPE OF ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH 2P23 ALK REARRANGEMENTS/
    The American journal of pathology
    
    S. Pittaluga et al., "THE MONOCLONAL-ANTIBODY ALK1 IDENTIFIES A DISTINCT MORPHOLOGICAL SUBTYPE OF ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH 2P23 ALK REARRANGEMENTS/", The American journal of pathology, 151(2), 1997, pp. 343-351
43. PILERI SA; PULFORD K; MORI S; MASON DY; SABATTINI E; RONCADOR G; PICCIOLI M; CECCARELLI C; PICCALUGA PP; SANTINI D; LEONE O; STEIN H; FALINI B
    FREQUENT EXPRESSION OF THE NPM-ALK CHIMERIC FUSION PROTEIN IN ANAPLASTIC LARGE-CELL LYMPHOMA, LYMPHO-HISTIOCYTIC TYPE
    The American journal of pathology
    
    S.A. Pileri et al., "FREQUENT EXPRESSION OF THE NPM-ALK CHIMERIC FUSION PROTEIN IN ANAPLASTIC LARGE-CELL LYMPHOMA, LYMPHO-HISTIOCYTIC TYPE", The American journal of pathology, 150(4), 1997, pp. 1207-1211
44. CHETTY R; PULFORD K; JONES M; MATHIEUMAHUL D; CLOSE P; HUSSEIN S; PALLESEN G; RALFKIAER E; STEIN H; GATTER K; MASON D
    AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242
    Journal of pathology
    
    R. Chetty et al., "AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242", Journal of pathology, 178(3), 1996, pp. 311-315
45. DELABESSE E; BERNARD M; MEYER V; SMIT L; PULFORD K; LANDMANPARKER J; STROMINGER JL; VARET B; VALENSI F; MACINTYRE E
    TAL-1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS
    Blood
    
    E. Delabesse et al., "TAL-1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS", Blood, 88(10), 1996, pp. 296-296
46. BOURQUELOT PM; MEYER V; DELABESSE E; BERNARD M; PULFORD K; GARAND R; IMBERT M; VALENSI F; VAREL B; FLANDRIN G; MACINTYRE EA
    EXPRESSION OF THE TAL1 PROTEIN IN AML - CORRELATION WITH MORPHOLOGY, IMMUNOPHENOTYPE, MOLECULAR-GENETICS AND PROGNOSIS
    Blood
    
    P.M. Bourquelot et al., "EXPRESSION OF THE TAL1 PROTEIN IN AML - CORRELATION WITH MORPHOLOGY, IMMUNOPHENOTYPE, MOLECULAR-GENETICS AND PROGNOSIS", Blood, 88(10), 1996, pp. 2251-2251
47. PULFORD K; JONES M; STROUD D; MASON DY
    IMMUNOCYTOCHEMICAL DISTRIBUTION OF THE CDW75 ANTIGEN
    Tissue antigens
    
    K. Pulford et al., "IMMUNOCYTOCHEMICAL DISTRIBUTION OF THE CDW75 ANTIGEN", Tissue antigens, 48(4-II), 1996, pp. 409-409
48. TURLEY H; BANHAM A; JONES M; PULFORD K; GATTER K; MASON D
    2 ANTI-PLASMA CELL ANTIBODIES RECOGNIZING A MOLECULE ASSOCIATED WITH ROUGH ENDOPLASMIC-RETICULUM
    Tissue antigens
    
    H. Turley et al., "2 ANTI-PLASMA CELL ANTIBODIES RECOGNIZING A MOLECULE ASSOCIATED WITH ROUGH ENDOPLASMIC-RETICULUM", Tissue antigens, 48(4-II), 1996, pp. 501-501
49. PULFORD K; JONES M; STROUD D; MASON DY
    FLOW CYTOMETRIC CHARACTERIZATION OF THE CYTOPLASMIC BLIND B-CELL PANEL OF REAGENTS
    Tissue antigens
    
    K. Pulford et al., "FLOW CYTOMETRIC CHARACTERIZATION OF THE CYTOPLASMIC BLIND B-CELL PANEL OF REAGENTS", Tissue antigens, 48(4-II), 1996, pp. 502-502
50. CHETTY R; CERRONI L; PULFORD K; GIATROMANOLAKI A; BIDDOLPH S; KAKLAMANIS L; GATTER K
    TAL1 GENE DELETIONS AND TAL1 PROTEIN EXPRESSION IN SPORADIC MELANOMA
    Melanoma research
    
    R. Chetty et al., "TAL1 GENE DELETIONS AND TAL1 PROTEIN EXPRESSION IN SPORADIC MELANOMA", Melanoma research, 5(4), 1995, pp. 251-254
51. TOOZE JA; SASO R; MARSH JCW; PAPADOPOULOS A; PULFORD K; GORDONSMITH EC
    THE NOVEL MONOCLONAL-ANTIBODY BY114 HELPS DETECT THE EARLY EMERGENCE OF A PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA CLONE IN APLASTIC-ANEMIA
    Experimental hematology
    
    J.A. Tooze et al., "THE NOVEL MONOCLONAL-ANTIBODY BY114 HELPS DETECT THE EARLY EMERGENCE OF A PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA CLONE IN APLASTIC-ANEMIA", Experimental hematology, 23(14), 1995, pp. 1484-1491
52. CHETTY R; PULFORD K; JONES M; MATHIEUMAHUL D; CLOSE P; HUSSEIN S; PALLESEN G; RALFKIAER E; STEIN H; GATTER K; MASON D
    SCL TAL-1 EXPRESSION IN T-ACUTE LYMPHOBLASTIC-LEUKEMIA - AN IMMUNOHISTOCHEMICAL AND GENOTYPIC STUDY/
    Human pathology
    
    R. Chetty et al., "SCL TAL-1 EXPRESSION IN T-ACUTE LYMPHOBLASTIC-LEUKEMIA - AN IMMUNOHISTOCHEMICAL AND GENOTYPIC STUDY/", Human pathology, 26(9), 1995, pp. 994-998
53. MASON DY; CORDELL JL; BROWN MH; BORST J; JONES M; PULFORD K; JAFFE E; RALFKIAER E; DALLENBACH F; STEIN H; PILERI S; GATTER KC
    CD79A - A NOVEL MARKER FOR B-CELL NEOPLASMS IN ROUTINELY PROCESSED TISSUE SAMPLES
    Blood
    
    D.Y. Mason et al., "CD79A - A NOVEL MARKER FOR B-CELL NEOPLASMS IN ROUTINELY PROCESSED TISSUE SAMPLES", Blood, 86(4), 1995, pp. 1453-1459
54. PULFORD K; LECOINTE N; LEROYVIARD K; JONES M; MATHIEUMAHUL D; MASON DY
    EXPRESSION OF TAL-1 PROTEINS IN HUMAN TISSUES
    Blood
    
    K. Pulford et al., "EXPRESSION OF TAL-1 PROTEINS IN HUMAN TISSUES", Blood, 85(3), 1995, pp. 675-684
55. BERNARD M; SMIT L; MACINTYRE E; MATTHIEUMAHUL D; PULFORD K
    NUCLEAR-LOCALIZATION OF THE SCL TAL1 BASIC HELIX-LOOP-HELIX PROTEIN IS NOT DEPENDENT ON THE PRESENCE OF THE BASIC DOMAIN/
    Blood
    
    M. Bernard et al., "NUCLEAR-LOCALIZATION OF THE SCL TAL1 BASIC HELIX-LOOP-HELIX PROTEIN IS NOT DEPENDENT ON THE PRESENCE OF THE BASIC DOMAIN/", Blood, 85(11), 1995, pp. 3356-3357
56. PEZZELLA F; MICKLEM K; TURLEY H; PULFORD K; JONES M; KOCIALKOWSKI S; DELIA D; AIELLO A; BICKNELL R; SMITH K; HARRIS AL; GATTER KC; MASON DY
    ANTIBODY FOR DETECTING P53 PROTEIN BY IMMUNOHISTOCHEMISTRY IN NORMAL-TISSUES
    Journal of Clinical Pathology
    
    F. Pezzella et al., "ANTIBODY FOR DETECTING P53 PROTEIN BY IMMUNOHISTOCHEMISTRY IN NORMAL-TISSUES", Journal of Clinical Pathology, 47(7), 1994, pp. 592-596
57. CORDELL JL; PULFORD K; TURLEY H; JONES M; MICKLEM K; DOUSSIS IA; TYLER X; MAYNE K; GATTER KC; MASON DY
    CELLULAR-DISTRIBUTION OF HUMAN-LEUKOCYTE ADHESION MOLECULE ICAM-3
    Journal of Clinical Pathology
    
    J.L. Cordell et al., "CELLULAR-DISTRIBUTION OF HUMAN-LEUKOCYTE ADHESION MOLECULE ICAM-3", Journal of Clinical Pathology, 47(2), 1994, pp. 143-147
58. PULFORD K; MICKLEM KJ; JONES M; PEZZELLA F; MAYNE KM; MORRISON H; THOMAS J; FALINI B; NORTON A; MASON DY
    A NOVEL INTERNAL ANTIGEN WHICH DISTINGUISHES GERMINAL CENTER CELLS FROM OTHER B-CELL TYPES
    Immunology
    
    K. Pulford et al., "A NOVEL INTERNAL ANTIGEN WHICH DISTINGUISHES GERMINAL CENTER CELLS FROM OTHER B-CELL TYPES", Immunology, 82(1), 1994, pp. 154-163
59. BJERKE K; HALSTENSEN TS; JAHNSEN F; PULFORD K; BRANDTZAEG P
    DISTRIBUTION OF MACROPHAGES AND GRANULOCYTES EXPRESSING L1 PROTEIN (CALPROTECTIN) IN HUMAN PEYERS-PATCHES COMPARED WITH NORMAL ILEAL LAMINAPROPRIA AND MESENTERIC LYMPH-NODES
    Gut
    
    K. Bjerke et al., "DISTRIBUTION OF MACROPHAGES AND GRANULOCYTES EXPRESSING L1 PROTEIN (CALPROTECTIN) IN HUMAN PEYERS-PATCHES COMPARED WITH NORMAL ILEAL LAMINAPROPRIA AND MESENTERIC LYMPH-NODES", Gut, 34(10), 1993, pp. 1357-1363
60. WEBSTER R; PULFORD K; JONES M; MICKLEM K; DEWAELE M; MAYNE K; TSE A; MASON DY
    ZB51 - A MONOCLONAL-ANTIBODY REACTIVE WITH HUMAN PLASMA-CELLS
    British Journal of Haematology
    
    R. Webster et al., "ZB51 - A MONOCLONAL-ANTIBODY REACTIVE WITH HUMAN PLASMA-CELLS", British Journal of Haematology, 84(4), 1993, pp. 602-607
61. DOUSSISANAGNOSTOPOULOU I; KAKLAMANIS L; CORDELL J; JONES M; TURLEY H; PULFORD K; SIMMONS D; MASON D; GATTER K
    ICAM-3 EXPRESSION ON ENDOTHELIUM IN LYMPHOID MALIGNANCY
    The American journal of pathology
    
    I. Doussisanagnostopoulou et al., "ICAM-3 EXPRESSION ON ENDOTHELIUM IN LYMPHOID MALIGNANCY", The American journal of pathology, 143(4), 1993, pp. 1040-1043